Emerging Treatment Approaches and Multidisciplinary Management of Unresectable Stage III Non-Small Cell Lung Cancer - Episode 4

Overcoming Barriers to Biomarker Testing in Unresectable NSCLC: Strategies for Improved Access and Implementation

This segment discusses the importance of biomarker testing in lung cancer, challenges in implementation such as tissue adequacy and result delays, and strategies to enhance testing in both academic and community settings through local champions and education.

Video content above is prompted by the following:

  • What are some barriers you encounter with biomarker testing in NSCLC?
  • Do you have any thoughts on how to expand appropriate testing, particularly in the community setting?